This panel will feature discussion around SDoH screening instruments, where and how they are used, new tools in development, and issues around implementation for various stakeholders. A key focus of the discussion will be about whether one standardized screening set is needed and the challenges in getting to that implementation.
Angela Hagan Humana Inc.
Caroline Fichtenberg University of California, San Francisco
Jessa (Engelberg) Anderson West Health Institute
Clare Tanner Michigan Public Health Institute